<![CDATA[How Will Data From ASCO GU 2026 Affect the Treatment Paradigm?]]>

Summary: Big news from the ASCO GU 2026 cancer meeting! Doctors Bupathi and Garmezy shared exciting new treatments for bladder, kidney, and prostate cancer. For bladder cancer, a powerful mix of two drugs (Padcev and Keytruda) worked so well that patients might not need traditional chemotherapy anymore. For kidney cancer, combining Welireg and Lenvima kept the disease from growing much longer than an older drug. Lastly, for prostate cancer, adding a radiation drug (Xofigo) to Xtandi helped patients live longer. These new tag-team drug combos are changing how doctors fight cancer!

For more details, see cancernetwork at cancernetwork.com/view/how-will-data-from-asco-gu-2026-impact-the-treatment-paradigm- (opens in new tab)